Abstract A029: AI-Driven Network-Based Discovery on TCGA-PAAD Identifies KRAS-Axis Drug-Repurposing Targets for Pancreatic Cancer Interception
AI-guided network analysis of TCGA-PAAD prioritizes biologically coherent KRAS-axis and stromal-inflammatory candidates with clinically available HER2, EGFR, MEK-, BRAF, and KRAS-pathway inhibitors, supporting hypothesis generation for future pancreatic cancer interception studies.